14-day Premium Trial Subscription Try For FreeTry Free
NASDAQ:CATB
Delisted

Catabasis Pharmaceuticals Stock Price (Quote)

$3.36
+0.195 (+6.16%)
At Close: May 27, 2022

Range Low Price High Price Comment
30 days $5.34 $19.02 Friday, 27th May 2022 CATB stock ended at $3.36. This is 6.16% more than the trading day before Thursday, 26th May 2022. During the day the stock fluctuated 6.65% from a day low at $3.16 to a day high of $3.37.
90 days $17.30 $19.02
52 weeks $16.32 $20.85

Historical Catabasis Pharmaceuticals prices

Date Open High Low Close Volume
Apr 27, 2021 $2.31 $2.36 $2.25 $2.28 233 310
Apr 26, 2021 $2.25 $2.34 $2.24 $2.31 252 653
Apr 23, 2021 $2.38 $2.42 $2.24 $2.25 291 118
Apr 22, 2021 $2.28 $2.49 $2.27 $2.37 480 440
Apr 21, 2021 $2.22 $2.36 $2.21 $2.32 240 106
Apr 20, 2021 $2.37 $2.39 $2.18 $2.25 382 101
Apr 19, 2021 $2.23 $2.45 $2.04 $2.43 989 532
Apr 16, 2021 $2.35 $2.35 $2.15 $2.24 771 663
Apr 15, 2021 $2.49 $2.53 $2.35 $2.37 396 912
Apr 14, 2021 $2.50 $2.62 $2.46 $2.47 361 462
Apr 13, 2021 $2.39 $2.55 $2.35 $2.53 298 767
Apr 12, 2021 $2.66 $2.67 $2.43 $2.44 698 857
Apr 09, 2021 $2.78 $2.78 $2.68 $2.71 236 098
Apr 08, 2021 $2.81 $2.82 $2.68 $2.78 280 207
Apr 07, 2021 $2.75 $2.90 $2.72 $2.81 400 678
Apr 06, 2021 $2.87 $2.87 $2.77 $2.78 239 202
Apr 05, 2021 $2.91 $2.92 $2.74 $2.86 259 653
Apr 01, 2021 $2.95 $2.95 $2.83 $2.87 288 873
Mar 31, 2021 $2.70 $2.93 $2.70 $2.89 463 306
Mar 30, 2021 $2.62 $2.73 $2.56 $2.68 308 963
Mar 29, 2021 $2.89 $2.96 $2.59 $2.63 831 420
Mar 26, 2021 $3.04 $3.04 $2.76 $2.88 513 896
Mar 25, 2021 $2.83 $3.05 $2.82 $3.00 468 726
Mar 24, 2021 $3.14 $3.20 $2.85 $2.88 538 997
Mar 23, 2021 $3.33 $3.33 $3.08 $3.13 435 001
Click to get the best stock tips daily for free!

About Catabasis Pharmaceuticals

Catabasis Pharmaceuticals Catabasis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics to treat inflammatory and metabolic diseases. Its product pipeline includes CAT-1004, an oral small molecule that has completed Phase 1 clinical trials for the treatment of duchenne muscular dystrophy (DMD); CAT-2054, which is in Phase I clinical trial for the treatment of hypercholesterolemia i... CATB Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT